PDSB — PDS BIOTECHNOLOGY CORP

Ownership history in XTX Topco Ltd  ·  7 quarters on record

This page tracks every 13F SEC filing in which XTX Topco Ltd reported a position in PDS BIOTECHNOLOGY CORP (PDSB). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.03% (2024 Q1)
Avg. % of fund
0.01%
First filed
2022 Q2
Last filed
2025 Q4
Quarters held
7
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 34,218 +14,519 +73.7% 0.00% $26K $0.77
2025 Q3 REDUCED 19,699 -4,836 -19.7% 0.00% $20K $1.01
2024 Q4 REDUCED 24,535 -42,647 -63.5% 0.00% $40K $1.63
2024 Q3 ADDED 67,182 +47,528 +241.8% 0.02% $257K $3.82
3 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    PDSB price (monthly, adj. close)

Other funds also holding PDSB

As of 2025 Q4 — sorted by position size

ARMISTICE CAPITAL, LLC 3Y 7Y 0.03% Ground Swell Capital, LLC 3Y 7Y 0.02% INSPIRION WEALTH ADVISORS, LLC 3Y 7Y 0.02% Tempus Wealth Planning, LLC 3Y 0.01% Wealth Group, Ltd. 0.01% Iron Gate Global Advisors LLC 3Y 7Y 0.01% Virtu Financial LLC 3Y 7Y 0.0% StoneX Group Inc. 3Y 7Y 0.0% BLAIR WILLIAM & CO/IL 3Y 7Y 0.0% GRANDFIELD & DODD, LLC 3Y 7Y 0.0%
← Back to XTX Topco Ltd Holdings